
Xcellon Biologics is a Contract Development and Manufacturing Organization (CDMO) specializing in complex biologics, including Antibody Drug Conjugates (ADCs), bioconjugates, bispecific antibodies, and T-cell engagers. They offer a comprehensive suite of services covering lead candidate selection, process development, analytical development, formulation development, and non-GMP manufacturing. Xcellon emphasizes innovation through the integration of machine learning for process optimization, aiming to improve efficiency and reduce development timelines. The company is strategically located in Maryland, near key US Federal healthcare agencies, and boasts a team with decades of collective experience, having contributed to over 8 product launches and 20+ IND filings. They position themselves as a partner for biopharmaceutical companies looking to accelerate the journey from discovery to market for life-saving therapies.

Xcellon Biologics is a Contract Development and Manufacturing Organization (CDMO) specializing in complex biologics, including Antibody Drug Conjugates (ADCs), bioconjugates, bispecific antibodies, and T-cell engagers. They offer a comprehensive suite of services covering lead candidate selection, process development, analytical development, formulation development, and non-GMP manufacturing. Xcellon emphasizes innovation through the integration of machine learning for process optimization, aiming to improve efficiency and reduce development timelines. The company is strategically located in Maryland, near key US Federal healthcare agencies, and boasts a team with decades of collective experience, having contributed to over 8 product launches and 20+ IND filings. They position themselves as a partner for biopharmaceutical companies looking to accelerate the journey from discovery to market for life-saving therapies.